Enhanced CXCL1 production and angiogenesis in adenosine-mediated lung disease

FASEB Journal

Volumn 21, Issue 4, 2007, Pages 1026-1036

  Mohsenin, Amir ^a,b   Burdick, Marie D ^c   Molina, Jose G ^a   Keane, Michael P ^c   Blackburn, Michael R ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenosine deaminase; Asthma; Chemokine; Macrophage

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME ACTIVITY; LUNG DISEASE; LUNG FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; CHEMOKINES, CXC; HUMANS; INTERLEUKIN-8; LUNG; LUNG DISEASES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC; POLYETHYLENE GLYCOLS; RECEPTORS, INTERLEUKIN-8B; SIGNAL TRANSDUCTION;

MUS;

EID: 33947667794     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-7301com     Document Type: Article

References (55)

1. Tanaka, H., Yamada, G., Saikai, T., Hashimoto, M., Tanaka, S., Suzuki, K., Fujii, M., Takahashi, H., and Abe, S. (2003) Increased airway vascularity in newly diagnosed asthma using a high-magnification bronchovideoscope. Am. J. Respir. Crit. Care. Med. 168, 1495-1499
2. Vrugt, B., Wilson, S., Bron, A., Holgate, S. T., Djukanovic, R., and Aalbers, R. (2000) Bronchial angiogenesis in severe glucocorticoid-dependent asthma. Eur. Respir. J. 15, 1014-1021
3. Li, X., and Wilson, J. W. (1997) Increased vascularity of the bronchial mucosa in mild asthma. Am. J. Respir. Crit. Care Med. 156, 229-233
4. Salvato, G. (2001) Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects. Thorax 56, 902-906
5. Charan, N. B., Baile, E. M., and Pare, P. D. (1997) Bronchial vascular congestion and angiogenesis. Eur. Respir. J. 10, 1173-1180
6. Burdick, M. D., Murray, L. A., Keane, M. P., Xue, Y. Y., Zisman, D. A., Belperio, J. A., and Strieter, R. M. (2005) CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling. Am. J. Respir. Crit. Care. Med. 171, 261-268
7. Turner-Warwick, M. (1963) Precapillary systemic-pulmonary anastomoses. Thorax 18, 225-237
8. Belperio, J. A., Keane, M. P., Burdick, M. D., Gomperts, B., Xue, Y. Y., Hong, K., Mestas, J., Ardehali, A., Mehrad, B., Saggar, R., Lynch, J. P., Ross, D. J., and Strieter, R. M. (2005) Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome. J. Clin. Invest. 115, 1150 -1162
9. Weber, J., Meyer, K. C., Banda, P., Calhoun, W. J., and Auerbach, R. (1989) Studies of bronchoalveolar lavage cells and fluids in pulmonary sarcoidosis. II. Enhanced capacity of bronchoalveolar lavage fluids from patients with pulmonary sarcoidosis to induce cell movement in vitro. Am. Rev. Respir. Dis. 140, 1450-1454
10. Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C. L., Ehlert, J. E., Burdick, M. D., and Strieter, R. M. (2000) CXC chemokines in angiogenesis. J. Leukoc. Biol. 68, 1-8
11. Luan, J., Shattuck-Brandt, R., Haghnegahdar, H., Owen, J. D., Strieter, R., Burdick, M., Nirodi, C., Beauchamp, D., Johnson, K. N., and Richmond, A. (1997) Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J. Leukoc. Biol. 62, 588-597
12. Kocher, A. A., Schuster, M. D., Bonaros, N., Lietz, K., Xiang, G., Martens, T. P., Kurlansky, P. A., Sondermeijer, H., Witkowski, P., Boyle, A., et al. (2006) Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines. J. Mol. Cell Cardiol. 40, 455-464
13. Belperio, J. A., Keane, M. P., Burdick, M. D., Gomperts, B. N., Xue, Y. Y., Hong, K., Mestas, J., Zisman, D., Ardehali, A., Saggar, R., et al. (2005) CXCR2/CXCR2 ligand biology during lung transplant ischemia-reperfusion injury. J. Immunol. 175, 6931-6939
14. Devalaraja, R. M., Nanney, L. B., Du, J., Qian, Q., Yu, Y., Devalaraja, M. N., and Richmond, A. (2000) Delayed wound healing in CXCR2 knockout mice. J. Invest. Dermatol. 115, 234-244
15. Varney, M. L., Johansson, S. L., and Singh, R. K. (2006) Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma. Am. J. Clin. Pathol. 125, 209-216
16. Dusseau, J. W., Hutchins, P. M., and Malbasa, D. S. (1986) Stimulation of angiogenesis by adenosine on the chick chorioallantoic membrane. Circ. Res. 59, 163-170
17. Meininger, C. J., Schelling, M. E., and Granger, H. J. (1988) Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. Am. J. Physiol. 255, H554-562
18. Ethier, M. F., Chander, V., and Dobson, J. G., Jr. (1993) Adenosine stimulates proliferation of human endothelial cells in culture. Am. J. Physiol. 265, H131-138
19. Torry, R. J., O'Brien, D. M., Connell, P. M., and Tomanek, R. J. (1992) Dipyridamole-induced capillary growth in normal and hypertrophic hearts. Am. J. Physiol. 262, H980-986
20. Feoktistov, I., Goldstein, A. E., Ryzhov, S., Zeng, D., Belardinelli, L., Voyno-Yasenetskaya, T., and Biaggioni, I. (2002) Differential expression of adenosine receptors in human endothelial cells: role of A2B receptors in angiogenic factor regulation. Circ. Res. 90, 531-538
21. Montesinos, M. C., Shaw, J. P., Yee, H., Shamamian, P., and Cronstein, B. N. (2004) Adenosine A(2A) receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis. Am. J. Pathol. 164, 1887-1892
22. Driver, A. G., Kukoly, C. A., Ali, S., and Mustafa, S. J. (1993) Adenosine in bronchoalveolar lavage fluid in asthma. Am. Rev. Respir. Dis. 148, 91-97
23. Huszar, E., Vass, G., Vizi, E., Csoma, Z., Barat, E., Molnar, V. G., Herjavecz, I., and Horvath, I. (2002) Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur. Respir. J. 20, 1393-1398
24. Blackburn, M. R., Datta, S. K., and Kellems, R. E. (1998) Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency. J. Biol. Chem. 273, 5093-5100
25. Blackburn, M. R., Volmer, J. B., Thrasher, J. L., Zhong, H., Crosby, J. R., Lee, J. J., and Kellems, R. E. (2000) Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J. Exp. Med. 192, 159-170
26. Feoktistov, I., and Biaggioni, I. (1995) Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J. Clin. Invest. 96, 1979-1986
27. Reid, D. W., Ward, C., Wang, N., Zheng, L., Bish, R., Orsida, B., and Walters, E. H. (2003) Possible anti-inflammatory effect of salmeterol against interleukin-8 and neutrophil activation in asthma in vivo. Eur. Respir. J. 21, 994-999
28. Thurston, G., Murphy, T. J., Baluk, P., Lindsey, J. R., and McDonald, D. M. (1998) Angiogenesis in mice with chronic airway inflammation: strain-dependent differences. Am. J. Pathol. 153, 1099-1112
29. Young, H. W., Molina, J. G., Dimina, D., Zhong, H., Jacobson, M., Chan, L.-N. L., Chan, T.-S., Lee, J. J., and Blackburn, M. R. (2004) A3 adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminasedeficient mice. J. Immunol. 173, 1380-1389
30. Knudsen, T. B., Winters, R. S., Otey, S. K., Blackburn, M. R., Airhart, M. J., Church, J. K., and Skalko, R. G. (1992) Effects of (R)-deoxycoformycin (pentostatin) on intrauterine nucleoside catabolism and embryo viability in the pregnant mouse. Teratology 45, 91-103
31. Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., and et al. (1995) The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270, 27348-27357
32. Keane, M. P., Arenberg, D. A., Lynch, J. P., III, Whyte, R. I., Iannettoni, M. D., Burdick, M. D., Wilke, C. A., Morris, S. B., Glass, M. C., DiGiovine, B., et al. (1997) The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J. Immunol. 159, 1437-1443
33. Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Glass, M., Burdick, M. D., and Strieter, R. M. (1996) Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J. Clin. Invest. 97, 2792-2802
34. Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Morris, S. B., Burdick, M. D., Glass, M. C., Taub, D. T., Iannettoni, M. D., Whyte, R. I., and Strieter, R. M. (1996) Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J. Exp. Med. 184, 981-992
35. Hasko, G., and Cronstein, B. N. (2004) Adenosine: an endogenous regulator of innate immunity. Trends. Immunol. 25, 33-39
36. Csoma, Z., Huszar, E., Vizi, E., Vass, G., Szabo, Z., Herjavecz, I., Kollai, M., and Horvath, I. (2005) Adenosine level in exhaled breath increases during exercise-induced bronchoconstriction. Eur. Respir. J. 25, 873-878
37. Jabs, C. M., Sigurdsson, G. H., and Neglen, P. (1998) Plasma levels of high-energy compounds compared with severity of illness in critically ill patients in the intensive care unit. Surgery 124, 65-72
38. Fredholm, B. B., AP, I. J., Jacobson, K. A., Klotz, K. N., and Linden, J. (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53, 527-552
39. Risau, W. (1997) Mechanisms of angiogenesis. Nature 386, 671-674
40. Chunn, J. L., Mohsenin, A., Young, H. W., Lee, C. G., Elias, J. A., Kellems, R. E., and Blackburn, M. R. (2006) Partially adenosine deaminase-deficient mice develop pulmonary fibrosis in association with adenosine elevations. Am. J. Physiol. Lung Cell Mol. Physiol. 290, L579-587
41. Lee, C. G., Link, H., Baluk, P., Homer, R. J., Chapoval, S., Bhandari, V., Kang, M. J., Cohn, L., Kim, Y. K., McDonald, D. M., and Elias, J. A. (2004) Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat. Med. 10, 1095-1103
42. Cebe-Suarez, S., Zehnder-Fjallman, A., and Ballmer-Hofer, K. (2006) The role of VEGF receptors in angiogenesis; complex partnerships. Cell Mol. Life Sci. 63, 601-615
43. Feoktistov, I., Ryzhov, S., Zhong, H., Goldstein, A. E., Matafonov, A., Zeng, D., and Biaggioni, I. (2004) Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype. Hypertension 44, 649-654
44. Arenberg, D. A., Keane, M. P., DiGiovine, B., Kunkel, S. L., Morris, S. B., Xue, Y. Y., Burdick, M. D., Glass, M. C., Iannettoni, M. D., and Strieter, R. M. (1998) Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J. Clin. Invest 102, 465-472
45. Nocker, R. E., Schoonbrood, D. F., van de Graaf, E. A., Hack, C. E., Lutter, R., Jansen, H. M., and Out, T. A. (1996) Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease. Int. Arch. Allergy Immunol. 109, 183-191
46. Modi, W. S., and Yoshimura, T. (1999) Isolation of novel GRO genes and a phylogenetic analysis of the CXC chemokine subfamily in mammals. Mol. Biol. Evol. 16, 180-193
47. Cavaillon, J. M., and Adib-Conquy, M. (2005) Monocytes/macrophages and sepsis. Crit. Care Med. 33, S506-509
48. Bobryshev, Y. V. (2006) Monocyte recruitment and foam cell formation in atherosclerosis. Micron 37, 208-222
49. Blackburn, M. R., Chun, G. L., Young, H. W. J., Chunn, J. L., Banerjee, S. K., and Elias, J. A. (2003) Adenosine mediates IL-13-induced inflammation and remodeling in the lung: evidence for an IL-13-adenosine amplification pathway. J. Clin. Invest. 112, 332-344
50. Xaus, J., Mirabet, M., Lloberas, J., Soler, C., Lluis, C., Franco, R., and Celada, A. (1999) IFN-gamma up-regulates the A2B adenosine receptor expression in macrophages: a mechanism of macrophage deactivation. J. Immunol. 162, 3607-3614
51. Chunn, J. L., Young, H. W., Banerjee, S. K., Colasurdo, G. N., and Blackburn, M. R. (2001) Adenosine-dependent airway inflammation and hyperresponsiveness in partially adenosine deaminase-deficient mice. J. Immunol. 167, 4676-4685
52. Sun, C. X., Zhong, H., Mohsenin, A., Morschl, E., Chunn, J. L., Molina, J. G., Belardinelli, L., Zeng, D., and Blackburn, M. R. (2006) Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. J. Clin. Invest. 116, 2173-2182
53. Desai, A., Victor-Vega, C., Gadangi, S., Montesinos, M. C., Chu, C. C., and Cronstein, B. N. (2005) Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1. Mol. Pharmacol. 67, 1406-1413
54. Addison, C. L., Daniel, T. O., Burdick, M. D., Liu, H., Ehlert, J. E., Xue, Y. Y., Buechi, L., Walz, A., Richmond, A., and Strieter, R. M. (2000) The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR CXC chemokine-induced angiogenic activity. J. Immunol. 165, 5269-5277
55. Moldobaeva, A., and Wagner, E. M. (2005) Difference in proangiogenic potential of systemic and pulmonary endothelium: role of CXCR2. Am. J. Physiol. Lung. Cell. Mol. Physiol. 288, L1117-1123